Fenoglide
Product Images NDC 52725-490

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fenoglide (NDC 52725-490). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Shore Therapeutics, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Fenoglide Figure 1)

Chemical structure diagram of the active ingredient in Fenoglide by Shore Therapeutics, Inc. The structure depicts a chlorophenyl group, aromatic rings, and ester functional groups characteristic of fenofibrate.*

FDA Label Image

Principal Display Panel (90 Tablet Bottle Label)

Label for Fenoglide tablets containing 40 mg fenofibrate, distributed by Shore Therapeutics, Inc. The label indicates a package of 90 tablets with NDC 52725-490-90. It includes storage instructions, dispensing information, and a barcode, with the statement Rx only.*

FDA Label Image

Principal Display Panel (90 Tablet Bottle Label)

Packaging label for Fenoglide 120 mg tablets containing the active ingredient fenofibrate. The label indicates a package size of 90 tablets with NDC 52725-495-90. It is labeled Rx only and distributed by Shore Therapeutics, Inc., Stamford, CT. The label includes storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.